Bausch + Lomb Shares Outstanding 2021-2024 | BLCO

Bausch + Lomb shares outstanding history from 2021 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Bausch + Lomb shares outstanding for the quarter ending September 30, 2024 were 0.354B, a 0.88% increase year-over-year.
  • Bausch + Lomb 2023 shares outstanding were 0.351B, a 0.09% increase from 2022.
  • Bausch + Lomb 2022 shares outstanding were 0.35B, a 0.06% increase from 2021.
  • Bausch + Lomb 2021 shares outstanding were 0.35B, a 0% decline from 2020.
Bausch + Lomb Annual Shares Outstanding
(Millions of Shares)
2023 351
2022 350
2021 350
2020 350
Bausch + Lomb Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 354
2024-06-30 352
2024-03-31 351
2023-12-31 351
2023-09-30 351
2023-06-30 351
2023-03-31 350
2022-12-31 350
2022-09-30 350
2022-06-30 350
2022-03-31 350
2021-12-31 350
2021-09-30 350
2021-06-30 350
2021-03-31 350
2020-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $6.301B $4.146B
Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $92.839B 12.14
Cencora (COR) United States $49.468B 18.60
DiDi Global (DIDIY) China $22.650B 0.00
Natera (NTRA) United States $22.209B 0.00
ICON (ICLR) Ireland $16.344B 14.56
Revvity (RVTY) United States $15.033B 26.11
Avantor (AVTR) United States $14.626B 21.93
BioMerieux (BMXMF) France $14.203B 0.00
Viatris (VTRS) United States $13.523B 4.17
CochLear (CHEOY) Australia $12.916B 0.00
Solventum (SOLV) United States $12.870B 0.00
Doximity (DOCS) United States $10.767B 63.37
Medpace Holdings (MEDP) United States $10.662B 30.04
EUROFINS SCIENT (ERFSF) Luxembourg $10.135B 0.00
HealthEquity (HQY) United States $9.429B 47.30
Sonic Healthcare (SKHHY) Australia $8.657B 0.00
Charles River Laboratories (CRL) United States $8.266B 15.97
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
BrightSpring Health Services (BTSG) United States $4.136B 87.96
Organon (OGN) United States $4.079B 4.11
Sotera Health (SHC) United States $3.875B 20.73
Surgery Partners (SGRY) United States $3.273B 37.32
Concentras Parent (CON) United States $2.998B 0.00
Alignment Healthcare (ALHC) United States $2.937B 0.00
Premier (PINC) United States $2.191B 11.40
Ardent Health Partners (ARDT) United States $2.098B 0.00
PACS (PACS) United States $2.080B 0.00
GeneDx Holdings (WGS) United States $2.079B 0.00
Progyny (PGNY) United States $1.980B 40.09
GoodRx Holdings (GDRX) United States $1.845B 48.40
Teladoc Health (TDOC) United States $1.782B 0.00
Agilon Health (AGL) United States $1.413B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Pediatrix Medical (MD) United States $1.219B 11.92
CareDx (CDNA) United States $1.210B 0.00
Embecta (EMBC) United States $1.070B 7.48
AMN Healthcare Services Inc (AMN) United States $1.036B 7.02
Establishment Labs Holdings (ESTA) $0.947B 0.00
Auna S.A (AUNA) Luxembourg $0.637B 0.00
SBC Medicals (SBC) United States $0.518B 0.00
InnovAge Holding (INNV) United States $0.505B 0.00
DocGo (DCGO) United States $0.490B 18.46
QDM (QDMI) Hong Kong, SAR China $0.480B 12.56
Sonida Senior Living (SNDA) United States $0.451B 0.00
Enhabit (EHAB) United States $0.422B 36.52
COMPASS Pathways (CMPS) United Kingdom $0.280B 0.00
MultiPlan (MPLN) United States $0.267B 0.00
LifeMD (LFMD) United States $0.248B 0.00
Nutex Health (NUTX) United States $0.243B 0.00
Sera Prognostics (SERA) United States $0.212B 0.00
Beauty Health (SKIN) United States $0.205B 0.00
Performant Healthcare (PHLT) United States $0.184B 0.00
Biodesix (BDSX) United States $0.151B 0.00
So-Young (SY) China $0.105B 17.83
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
IceCure Medical (ICCM) Israel $0.068B 0.00
ModivCare (MODV) United States $0.066B 3.57
Oncology Institute (TOI) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.050B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.038B 0.00
OncoCyte (OCX) United States $0.034B 0.00
Co-Diagnostics (CODX) United States $0.025B 0.00
Pheton Holdings (PTHL) China $0.024B 0.00
KindlyMD (KDLY) United States $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00